Rhenovia Pharma Language Contact
    Rhenovia Pharma    

Stay connected & subscribe to Rhenovia News Feed

5 February 2012 - Rhenovia Pharma opens first US office

Rhenovia Pharma Expands activities to the Greater Boston Area

Deployment will widen use of biosimulation technology

Mulhouse, France and Cambridge, Massachusetts, USA, January 25, 2012 - Rhenovia Pharma SAS, a biotechnology company specializing in biosimulation applied to the discovery of new medications to treat brain diseases such as Alzheimer's, today announces its first international subsidiary, Rhenovia Inc., incorporated in Delaware.

Rhenovia 120125 US subsidiary EN.pdf